PPARγ activation with exogenous ligands suchas the TZDs would be predicted to confer significant benefits inthis setting, through the amelioration of insulin resistance,dyslipidaemia, and possibly hypertension, albeit at a potentialcost of mild weight gain (as a consequence of enhancedadipogenesis and fluid retention). Here, PPARG is linked to inherited lipid metabolism disorder.